Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/14/2006WO2006121979A3 Modified-release pharmaceutical compositions
12/14/2006WO2006116733A3 Protein kinase inhibitors
12/14/2006WO2006116596A3 Micronized tanaproget and compostions containing same
12/14/2006WO2006116583A3 Compositions comprising a polymerized benzimidazole and a buffering agent and methods of using same
12/14/2006WO2006116514A3 Micronized tanaproget, compositions, and methods of preparing the same
12/14/2006WO2006116498A3 Purified form of tanaproget
12/14/2006WO2006115987A3 Use of a clobetasol spray formulation to treat psoriasis
12/14/2006WO2006115835A3 Benzothiophene hydroxamic acid derivatives
12/14/2006WO2006115412A3 Nutrition with lipids and non-digestible saccharides
12/14/2006WO2006113981A3 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method
12/14/2006WO2006113842A3 Method and composition for inhibiting cell proliferation and angiogenesis
12/14/2006WO2006113571A3 Substituted cyclopentanones for treating inflammatory bowel disease
12/14/2006WO2006112705A3 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure.
12/14/2006WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
12/14/2006WO2006108424A3 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
12/14/2006WO2006107948A3 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
12/14/2006WO2006107062A3 Benzimidazole derivative and use as angiotensin ii antagonist
12/14/2006WO2006105670A8 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
12/14/2006WO2006102684A3 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells
12/14/2006WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors
12/14/2006WO2006101977A3 Pyrimidine compounds and methods of use
12/14/2006WO2006100225A3 Benzoic acid ester compounds, compositions, uses and methods related thereto
12/14/2006WO2006096970A8 Synthetic anti-candida albicans oligosaccharide based vaccines
12/14/2006WO2006095363A3 Injectable preparations of diclofenic and its pharmaceutically acceptable salts
12/14/2006WO2006095139A3 Cancer treatment using specific 3,6,9-substituted acridines
12/14/2006WO2006094917A3 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors
12/14/2006WO2006094246A3 N-arylmethyl benzamide sirtuin modulators
12/14/2006WO2006093774A3 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy
12/14/2006WO2006092727A9 Process for the production of calcium compositions in a continuous fluid bed
12/14/2006WO2006091544A3 Methods and compositions for modulating calcium channels
12/14/2006WO2006091442A3 Transdermal systems having control delivery system
12/14/2006WO2006089211A3 Combat/training antioxidant micronutrient formulation and method of administration
12/14/2006WO2006089177A3 Isoxazole combretastin derivatives for the treatment of disorders
12/14/2006WO2006087752A8 Cationic lipids for the transfection of nucleic acids
12/14/2006WO2006086488A3 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
12/14/2006WO2006085302A3 Composition for treatment of skin disorders
12/14/2006WO2006084911A3 Improved device for application of medicaments, manufacturing method therefor, and method of treatment
12/14/2006WO2006084200A3 Nitroxides for use in treating or preventing cardiovascular disease
12/14/2006WO2006084058A3 Method for treating gefitinib resistant cancer
12/14/2006WO2006083678A3 β-CYCLODEXTRIN DERIVATIVES AS ANTIBACTERIAL AGENTS
12/14/2006WO2006083328A3 Biologically active surfaces and methods of their use
12/14/2006WO2006082409A3 Tricyclic cytoprotective compounds
12/14/2006WO2006081554A3 Phenyl-substituted pyrrolidones
12/14/2006WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
12/14/2006WO2006081289A3 Antibacterial agents
12/14/2006WO2006078925A3 A tetracycline metal complex in a solid dosage form
12/14/2006WO2006078274A3 Beta-peptides
12/14/2006WO2006075932A3 Remedy to accelerate healing of wound and burn
12/14/2006WO2006075095A3 Use of purine derivatives as hsp90 protein inhibitors and for treatment of cancer
12/14/2006WO2006072636A3 1, 5, 6-substituted-2-oxo-3-cyano-1, 6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
12/14/2006WO2006071912A3 A method for treating or preventing pruritic and neurogenic skin disorders by applying sertaconazole
12/14/2006WO2006069326A3 Polyethylene glycolated superoxide dismutase mimetics
12/14/2006WO2006068668A3 Compositions and methods for modulating calcium flux, glucose homeostasis and apoptosis
12/14/2006WO2006066267A3 Cancer treatment method
12/14/2006WO2006066079A3 Pyridazinone compounds
12/14/2006WO2006053766A8 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol
12/14/2006WO2006050457A3 Methods and compositions for treating chronic lymphocytic leukemia
12/14/2006WO2006049764A3 Methods of making 2,6-diaryl piperidine derivatives
12/14/2006WO2006034473A3 Novel pyrimidine compounds, process for their preparation and compositions containing them
12/14/2006WO2006034219A3 Inactivation of microorganisms with multidrug resistance inhibitors and phenothiaziniums
12/14/2006WO2006031376A3 Use of antioxidants for treating degenerative disc disease
12/14/2006WO2006017505A3 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
12/14/2006WO2006014913A3 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
12/14/2006WO2006014787A3 Compositions containing policosanol and b vitamins and their pharmaceutical uses
12/14/2006WO2005123074A9 Use of a compound in the treatment of sleep disorders
12/14/2006WO2005120643A8 Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms
12/14/2006WO2005120497A3 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
12/14/2006WO2005113571A3 Methods for the delivery of oligomeric compounds
12/14/2006WO2005112648A8 Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake
12/14/2006WO2005110428A3 Resistance-repellent retroviral protease inhibitors
12/14/2006WO2005102338A8 Method of treating neuropathic pain using a crth2 receptor antagonist
12/14/2006WO2005100322A8 Sulphur-linked imidazole compounds for the treament of hiv
12/14/2006WO2005079752A3 Controlled release pharmaceutical compositions with improved bioavailability
12/14/2006WO2005075425A3 Substituted bisarylurea derivatives as kinase inhibitors
12/14/2006WO2005067627A3 Cosmetic composition and method for retarding hair growth
12/14/2006WO2005053644A8 A medical product comprising tiotropium in a moisture-proof container
12/14/2006WO2004093794A3 Antimicrobial medical articles containing a combination of anti-infective compounds, octoxyclycerin, salicylic acid, and sesquiterpenoids
12/14/2006WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006US20060282909 Methods and compositions for therapeutic intervention in cardiac hypertrophy
12/14/2006US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis
12/14/2006US20060281902 Human signal peptide-containing proteins
12/14/2006US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006US20060281822 Treatment and prevention of elevated homocysteine
12/14/2006US20060281821 Retinoid replacements and opsin agonists and methods for the use thereof
12/14/2006US20060281820 Lfa-1 inhibitors and use thereof
12/14/2006US20060281819 Suppression of HIV-1 replication via inhibition of human flap endonuclease-1-mediated HIV-1 central DNA flap processing
12/14/2006US20060281818 Method for treating mucosal disorders
12/14/2006US20060281817 Treatment for neurodegenerative diseases
12/14/2006US20060281816 Pregabalin free of lactam and a process for preparation thereof
12/14/2006US20060281815 Conjugated linolenic acids and methods of preparation and purification and uses thereof
12/14/2006US20060281814 Conjugated linolenic acids and methods for commerical preparation and purification
12/14/2006US20060281813 Methods of treating hyperproliferative cell disorders
12/14/2006US20060281812 For urogenital disorders; improved side effect reduction, bioavailability, pharmacokinetics and half-life; N,N-diisopropyl-3-(2-methoxy-5-trifluoromethylphenyl)-3-phenylpropanamine tartrate
12/14/2006US20060281811 Synthesis of taxol enhancers
12/14/2006US20060281810 Novel anthranilic acid derivatives
12/14/2006US20060281809 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
12/14/2006US20060281808 Sovlent extraction of quassin and neoquassin with ethanol, evaporation, washing with hexane, saturation with sodium chloride, extraction with ethyl acetate, crystallization, separating mother liquor by column chromatography, crystallizing any additional quassinoids; nontoxic
12/14/2006US20060281807 Quassinoid compositions for the treatment of cancer and other proliferative diseases
12/14/2006US20060281806 Treatment and inhibition of disease conditions using flexible heteroarotinoids
12/14/2006US20060281805 highly potent; side effect reduction; for the treatment of diseases of the respiratory, urinary and gastrointestinal systems; 3-(2-Methoxy-5-methylphenyl)-3-phenylpropionic acid-(3-benzyl-3-azabicyclo[3.1.0]hex-6-yl-carbamoyl)methyl ester; condensation; deprotection